Cue Health Q3 2023 Adj EPS $(0.42) Beats $(0.45) Estimate, Sales $17.48M Beat $16.66M Estimate
Portfolio Pulse from totan@benzinga.com
Cue Health (NASDAQ:HLTH) reported Q3 2023 adjusted EPS of $(0.42), beating the estimate of $(0.45) by 6.67%. The company also reported quarterly sales of $17.48M, surpassing the estimate of $16.66M by 4.90%. However, this represents a 74.89% decrease in sales compared to the same period last year.
November 08, 2023 | 9:43 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cue Health's Q3 2023 earnings beat estimates, but sales have significantly decreased compared to the same period last year.
While Cue Health beat earnings estimates, the significant decrease in sales compared to the same period last year could potentially offset any positive impact from the earnings beat. This could lead to a neutral short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100